Natriuretic peptide and cardiac troponin levels in doxorubicin-induced cardiotoxicity (Author`s Reply)

References (1)

1. Argun M, Üzüm K, Sönmez MF, Özyurt A, Karabulut D, Soyersarıca Z, et al. Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats. Anatol J Cardiol 2015 Apr 30. Epub ahead of print. 2.Cardinale D, Sandri MT, Colombo A, Colombo N, Boeri M, Lamantia G, et al. Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotheraphy. Circula-tion 2004; 109: 2749-54. 3.Sandri MT, Salvatici M, Cardinale D, Zorzino L, Passerini R, Lentati P, et al. N-terminal pro-B-type natriuretic peptide after high-dose chemotheraphy: a marker predictive of cardiac dysfunction? Clin Chem 2005; 51: 1405-10. 4.Koh E, Nakamura T, Takahashi H. Troponin T and brain natriuretic peptide as predictors for adriamycin-induced cardiomyopathy in rats. Circ J 2004; 68: 163-7. 5.Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Cohen V, et al. Early detection and prediction of cardiotoxicity in chemotheraphy-treated patients. Am J Cardiol 2011; 107: 1375-80.